Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Nov 20 2018

Full Issue

FDA Eyes Smartphone Apps Linked To Prescription Drugs In Part Of Flurry Of New Digital Health Guidelines

FDA Commissioner Scott Gottlieb has proposed treating some of the apps like "promotional material," which would allow companies to make minor updates without having to go back to the agency for approval.

Stat: FDA Proposes New Regulations For Some Health Smartphone Apps 

The Food and Drug Administration wants to ramp up the way it regulates smartphone apps linked to prescription drugs — like medication reminders or symptom trackers. In a new proposal released Monday, the agency said it may treat some apps like drug advertisements — which would allow companies to distribute apps without going through a review process with every update. Right now, the apps aren’t covered by existing regulations. (Sullivan, 11/19)

In other news from the FDA —

The Wall Street Journal: FDA Menthol Ban Will Be A Slow Burn

The Food and Drug Administration’s war on menthol cigarettes could take years. Investors have time to sift the ashes and decide which tobacco stocks are best prepared for tougher U.S. regulations and a shift to alternative forms of smoking. FDA Commissioner Scott Gottlieb last week said he wants to ban menthol brands, which are more addictive than regular tobacco, but didn’t give a timeline. He will immediately restrict sales of flavored e-cigarettes to fight rocketing use among young Americans—3.6 million middle- and high-school students are now e-smokers, up from 2.1 million in 2017. (Ryan, 11/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF